We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.75 | 8.11% | 10.00 | 9.50 | 10.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 10.25 | 9.50 | 9.50 | 2,406,481 | 15:37:19 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Business Services, Nec | 2.19M | -20.13M | -0.0624 | -1.60 | 29.84M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 28/4/2025 | 07:00 | UK RNS | Angle PLC RESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME |
| 21/3/2025 | 14:25 | ALNC |  Angle hails successful completion of Eisai contract; approval by Astra |
| 21/3/2025 | 07:00 | UK RNS | Angle PLC Issue of LTIP Options and Share Options |
| 21/3/2025 | 07:00 | UK RNS | Angle PLC Results of Eisai Phase 2 pilot study |
| 06/2/2025 | 07:00 | UK RNS | Angle PLC Novel findings using Parsortix |
| 29/1/2025 | 16:26 | ALNC | Angle reports breakthrough in dual cancer DNA analysis |
| 29/1/2025 | 07:00 | UK RNS | Angle PLC Analysis of CTC-DNA and ctDNA using Illumina assay |
| 24/1/2025 | 10:05 | UK RNS | Angle PLC Parsortix used in research paper from ETH Zurich |
| 23/1/2025 | 14:22 | ALNC | Angle fails to win market confidence despite narrowing loss in 2024 |
| 23/1/2025 | 07:00 | UK RNS | Angle PLC Trading Update |
1 Year Angle Chart |
Intraday Angle Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
